EUVIMEDEUVIMED entdecken
Multizentrische Studie

Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation

Pascal B Meyre iD, Hyo-Jeong Ahn iD, Carolin A Ehlert iD, Tsai-Sang Dederichs, Stefanie Aeschbacher iD, Andreas S Müller iD, Jürg H Beer iD, Tobias Reichlin iD, Nicolas Rodondi iD, Elisavet Moutzouri iD, Steffen Schneider iD, Uwe Zeymer iD und 14 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.126.079459 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, 2026. Verfasst von Pascal B Meyre und 25 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute (P.B.M., M.C., G.P., D.C.), McMaster University, Hamilton, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Clonal Hematopoiesis, Cognitive Dysfunction, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) has been associated with cardiovascular disease, but its relationship with silent brain lesions and cognitive decline in patients with atrial fibrillation (AF) is unclear. METHODS: In this prospective, multicenter cohort study, we included 1572 patients with AF enrolled between 2014 and 2017. All participants underwent deep-targeted sequencing for CHIP-associated sequence variations, brain magnetic resonance imaging, and standardized cognitive assessments. CHIP carrier status (overall, DNMT3A carrier, and non- DNMT3A carrier) was evaluated in relation to prevalent and incident silent brain lesions. Silent brain lesions were defined as large noncortical or cortical infarcts, small noncortical infarcts, microbleeds, and white matter lesions (WMLs), and were assessed at baseline and after 2 years with magnetic resonance imaging. Cross-sectional analyses were externally validated in a cohort of 199 patients with AF. Cognitive function was evaluated through 7 years using the Montreal Cognitive Assessment. Associations were analyzed using multivariable-adjusted logistic and linear regression models. RESULTS: Among 1572 patients with AF (mean±SD age, 72.5±8.3 years; 26% women), 342 (22%) carried CHIP sequence variations, most commonly in DNMT3A (49.4%) and TET2 (28.3%). CHIP carriers had significantly higher odds of cerebral microbleeds (odds ratio [OR], 1.45 [95% CI, 1.09 to 1.93]) and WMLs (OR, 1.56 [95% CI, 1.20 to 2.04]) at baseline, particularly with non- DNMT3A sequence variations (microbleeds: OR, 1.79 [95% CI, 1.25 to 2.55]; WMLs: OR, 1.80 [95% CI, 1.25 to 2.62]). A similar trend was observed in an independent AF patient cohort from Korea limited to TET2 sequence variations. Presence of multiple CHIP sequence variations further increased the odds of microbleeds (OR, 1.36 [95% CI, 1.10 to 1.69]) and WMLs (OR, 1.41 [95% CI, 1.15 to 1.75]), and large CHIP clones (variant allele frequency >10%) were associated with higher WML volumes. At 2-year follow-up, CHIP was associated with new cerebral microbleed counts and greater WML volume. Over 7 years, CHIP carriers exhibited greater cognitive decline, with a lower Montreal Cognitive Assessment score compared with noncarriers (β −0.53 [95% CI, −1.02 to −0.03]). The decline was more pronounced in DNMT3A and ASXL1 sequence variation carriers. CONCLUSIONS: In patients with AF, CHIP was independently associated with a greater burden and progression of silent brain lesions and with accelerated cognitive decline. GRAPHIC ABSTRACT: A graphic abstract is available for this article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationClonal HematopoiesisCognitive DysfunctionBrainHumansFemaleMaleProspective StudiesAgedDNA Methyltransferase 3AMagnetic Resonance ImagingDNA (Cytosine-5-)-MethyltransferasesAged, 80 and overCross-Sectional StudiesMiddle AgedDNA-Binding ProteinsDioxygenases

Stichwörter der Autor:innen

atrial fibrillationclonal hematopoiesiscognitive dysfunctionmagnetic resonance imaging

Substanzen

DNMT3A protein, humanDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesTET2 protein, humanDNA-Binding ProteinsDioxygenases

Autor:innen und Institutionen

  • Population Health Research Institute (P.B.M., M.C., G.P., D.C.), McMaster University, Hamilton, Canada.
  • Division of Cardiology, Department of Medicine (P.B.M., S.A., S.O., F.M., C.S.Z., M.K.), University Hospital Basel, Switzerland.
  • Cardiovascular Research Institute Basel (P.B.M., S.A., S.O., F.M., C.S.Z., M.K.), University Hospital Basel, Switzerland.
  • Department of Internal Medicine, Seoul National University Hospital, Republic of Korea (H.-J.A., E.-K.C.).
  • Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Germany (C.A.E., T.-S.D., U.Z., C.v.z.M., D. Wolf, D. Westermann).
  • Department of Cardiology, Triemli Hospital Zurich, Switzerland (A.S.M.).

ORCID-Profile: Pascal B Meyre, Hyo-Jeong Ahn, Carolin A Ehlert, Stefanie Aeschbacher, Andreas S Müller, Jürg H Beer, Tobias Reichlin, Nicolas Rodondi, Elisavet Moutzouri, Steffen Schneider, Uwe Zeymer, Dennis Wolf, Dirk Westermann, Giorgio Moschovitis, Leo H Bonati, Stefan Osswald, Felix Mahfoud, Christine S Zuern, Michael Chong, Guillaume Paré, David Conen, Eue-Keun Choi, Michael Kühne, Ingo Hilgendorf

Zitieren

APA

Meyre, P. B., Ahn, H. J., Ehlert, C. A., Dederichs, T. S., Aeschbacher, S., Müller, A. S., Beer, J. H., Reichlin, T., Rodondi, N., Moutzouri, E., Schneider, S., Zeymer, U., von Zur Mühlen, C., Wolf, D., Westermann, D., Moschovitis, G., Bonati, L. H., Osswald, S., Mahfoud, F., …, & Hilgendorf, I. (2026). Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation. Circulation. https://doi.org/10.1161/circulationaha.126.079459

Vancouver

Meyre PB, Ahn HJ, Ehlert CA, Dederichs TS, Aeschbacher S, Müller AS, et al. Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation. Circulation. 2026. doi:10.1161/circulationaha.126.079459

BibTeX
@article{Meyre2026,
  author = {Meyre, Pascal B and Ahn, Hyo-Jeong and Ehlert, Carolin A and Dederichs, Tsai-Sang and Aeschbacher, Stefanie and Müller, Andreas S and Beer, Jürg H and Reichlin, Tobias and Rodondi, Nicolas and Moutzouri, Elisavet and Schneider, Steffen and Zeymer, Uwe and von Zur Mühlen, Constantin and Wolf, Dennis and Westermann, Dirk and Moschovitis, Giorgio and Bonati, Leo H and Osswald, Stefan and Mahfoud, Felix and Zuern, Christine S and Chong, Michael and Paré, Guillaume and Conen, David and Choi, Eue-Keun and Kühne, Michael and Hilgendorf, Ingo},
  title = {Association of Clonal Hematopoiesis With Silent Brain Lesions and Cognitive Decline in Patients With Atrial Fibrillation},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.126.079459}
}
Kostenlos starten →